This article explains how data in GMP is controlled across its lifecycle, focusing on pharmaceutical data integrity, audit trail review, and electronic records compliance. It highlights regulatory expectations under ALCOA+ principles, FDA guidance, and Annex 11 requirements for inspection readiness.